The first Alexion Pharmaceuticals trade was made in Q1 2014.
Since then Ray Dalio bought shares nine more times and sold shares on twelve occasions. The investor completely sold their stake between Q1 2021 and Q3 2021.
Avg closing price
Price range
Sold -4.3 Thousand shares
Q3 2021
Avg closing price
$183.75
Price range
$179.45
-
$186.61
Sold 30.7% shares (-1.91 Thousand shares)
Q2 2021
Avg closing price
$171.66
Price range
$152.35
-
$184.30
Sold 34.6% shares (-3.29 Thousand shares)
Q1 2021
Avg closing price
$154.69
Price range
$148.19
-
$161.75
New holding (+9.5 Thousand shares)
Q4 2020
Avg closing price
$128.50
Price range
$111.55
-
$158.03
Sold -475 Thousand shares
Q4 2019
Avg closing price
$106.96
Price range
$94.84
-
$115.45
Increased shares by 1472.3% (+445 Thousand shares)
Q3 2019
Avg closing price
$112.72
Price range
$95.18
-
$134.08
New holding (+30.2 Thousand shares)
Q2 2019
Avg closing price
$128.89
Price range
$113.68
-
$141.30
Sold -278 Thousand shares
Q1 2019
Avg closing price
$124.34
Price range
$98.05
-
$137.75
New holding (+278 Thousand shares)
Q4 2018
Avg closing price
$118.20
Price range
$93.94
-
$137.12
Sold -17.1 Thousand shares
Q3 2018
Avg closing price
$125.44
Price range
$115.32
-
$139.01
New holding (+17.1 Thousand shares)
Q2 2018
Avg closing price
$116.87
Price range
$106.04
-
$127.57
Sold -65.2 Thousand shares
Q1 2018
Avg closing price
$119.53
Price range
$108.33
-
$128.09
Sold 44.5% shares (-52.2 Thousand shares)
Q4 2017
Avg closing price
$121.78
Price range
$106.78
-
$143.84
Increased shares by 1735.2% (+111 Thousand shares)
Q3 2017
Avg closing price
$135.86
Price range
$121.08
-
$146.69
Sold 52.1% shares (-6.97 Thousand shares)
Q2 2017
Avg closing price
$116.39
Price range
$97.70
-
$133.41
New holding (+13.4 Thousand shares)
Q1 2017
Avg closing price
$128.92
Price range
$118.53
-
$144.77
Sold -29.1 Thousand shares
Q2 2015
Avg closing price
$172.57
Price range
$155.01
-
$190.92
Increased shares by 57.2% (+10.6 Thousand shares)
Q1 2015